CDC is requesting OMB approval for 3-years to implement a revised data collection form called, Report of Verified Case of Tuberculosis (RVCT)for the national tuberculosis (TB) surveillance system. Respondents to the revised collection remain as before, territorial, state, and local public health departments in 60 reporting areas (50 states, the District of Columbia, New York City, Puerto Rico, and 7 jurisdictions in the Pacific and Caribbean). This request updates the RVCT information collection data collection form to reflect stakeholder requirements and changes in TB diagnostics, drugs, and epidemiology since 1993. In 1993, the RVCT was approved to collect information to monitor factors essential to the reversal of the epidemic, including drug resistance, risk factors such as HIV co-infection or living in congregate settings such as prisons, and TB drug therapy. National TB surveillance system data assist federal, state, and local public health officials and policy makers in program planning, evaluation, and resource allocation. CDC publishes summarized data on TB in the United States annually, which is disseminated to TB control officers, pulmonary and infectious disease experts, and others interested in TB control.
US Code:
42 USC 301
Name of Law: Public Service Act
The changes incorporated into the updated RVCT form are in response to requests by stakeholders as described in section A.8 In brief, revisions to the currently approved RVCT include ability to capture TB risk factors such as diabetes, end-stage renal disease, anti-tumor necrosis factor alpha therapy, and contact with an infectious TB case. Revisions to the data collections will improve TB monitoring in the U.S. and particularly for pediatric TB patients. The revisions to the data collection will now reveal the primary reason for TB disease evaluation, whether the patient moved during TB treatment, immigration status for TB screening purposes, reason TB therapy extended if more than one year, and susceptibility testing for newer TB drugs. Enhancements to the RVCT will also accommodate changes in diagnostic technology since 1993, such as nucleic acid amplification tests, in
$1,146,526
No
Yes
Uncollected
Uncollected
Uncollected
Uncollected
Petunia Gissendaner 4046390164
Reginfo record details
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Form CDC 72.9A Report of Verified Case of Tuberculosis (RVCT)
Attachment 7.pdf
Attachment 6.doc
Report of Verified Case of Tuberculosis (RVCT)